TXMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
TherapeuticsMD Inc (TXMD) is not a strong buy for a beginner, long-term investor at this moment. Despite insider buying and a bullish technical setup, the company's poor financial performance, lack of recent news catalysts, and no significant trading signals make it prudent to hold off on investing right now.
The technical indicators show a bullish trend with MACD positively expanding, SMA_5 > SMA_20 > SMA_200, and the RSI at a neutral 60.865. The stock is trading near its resistance level (R1: 2.218) in pre-market, suggesting limited immediate upside.
Insider buying has increased significantly by 399.50% over the last month, indicating confidence from company insiders.
The company's financial performance in Q4 2025 is weak, with a significant drop in net income (-345.63% YoY) and EPS (-350.00% YoY). Additionally, there is no recent news or event-driven catalysts to support a strong buy decision.
In Q4 2025, revenue increased by 33.88% YoY to $893,000, but net income dropped significantly to -$619,000, and EPS fell to -$0.05. Gross margin remained stable at 100%.
No recent analyst ratings or price target changes are available for TXMD.
